Patients with ESD-derived artificial ulcers were randomly assigned to two groups : a group of patients who received rabeprazole 20 mg daily for 8 weeks ( PPI group ) and a group of patients who received a combination of rebamipide 300 mg daily for 8 weeks and rabeprazole 20 mg dairy for the first 4 weeks ( reb + PPI group ) .